Abstract
Purpose
To investigate whether pretreatment magnetic resonance (MR)-based radiomics nomogram can individualize prediction of perineural invasion (PNI) status in rectal cancer (RC).
Material and methods
A total of 122 RC patients with pathologically confirmed were classified as training cohort (n = 87) and test cohort (n = 35). 180 radiomics features were extracted from all lesions based on oblique axial T2WI TSE images. The dimensionality reduction and feature selection in training cohort were realized by the maximum relevance minimum redundancy (mRMR) algorithm and the least absolute shrinkage and selection operator (LASSO) regression model. A predictive model combining radiomics features and clinical risk factors (pathological N stage, pathological LVI status) was established by multivariate logistic regression analysis. The performance of the model was assessed based on its receiver operating characteristic (ROC) curve, nomogram, and calibration.
Results
The developed radiomics nomogram that integrated the radiomics signature and clinical risk factors could provide discrimination in the training and test cohorts. The accuracy and the area under the curve (AUC) for assessing PNI status were 0.82, 0.86, respectively, in the training cohort, while they were 0.71 and 0.85 in the test cohort. The goodness-of-fit of the nomogram was evaluated using the Hosmer–Lemeshow test (p = 0.52 in training cohort and p = 0.24 in test cohort). Decision curve analysis (DCA) showed that the radiomics nomogram was clinically useful.
Conclusion
The developed radiomics nomogram might be helpful in the individualized assessment PNI status in patients with RC. This stratification of RC patients according to their PNI status may provide the basis for individualized adjuvant therapy, especially for stage II patients.
Similar content being viewed by others
Abbreviations
- AUC:
-
Area under curve
- CI:
-
Confidence interval
- RC:
-
Rectal cancer
- LVI:
-
Lymphovascular invasion
- PNI:
-
Perineural invasion
- MR:
-
Magnetic resonance
- RLM:
-
Run-length matrix
- GLCM:
-
Gray-level co-occurrence matrix
- GLZSM:
-
Parameters and Gray-Level Size Zone Matrix
- PACS:
-
Picture archiving and communication system
- ROC:
-
Receiver operating characteristic
- AJCC:
-
American Joint Commission Cancer
- mRMR:
-
Maximum relevance minimum redundancy
- LASSO:
-
Least absolute shrinkage and selection operator
- DCA:
-
Decision curve analysis
- NCCN:
-
National comprehensive cancer network
References
Ferlay J, Colombet M, Soerjomataram, et al (2019) Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 144:1941–1953.
Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 7:1471–1474.
Al B Benson, Alan P Venook, Mahmoud M Al-Hawary,et al (2018) Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 16:874–901.
Turner MC, Keenan JE, Rushing CN, et al (2019) Adjuvant Chemotherapy Improves Survival Following Resection of Locally Advanced Rectal Cancer with Pathologic Complete Response. J Gastrointest Surg 23:1614–1622.
Milinis K, Thornton M, Montazeri A, et al (2015) Adjuvant chemotherapy for rectal cancer: Is it needed? World J Clin Oncol. 6:225–236.
Petrelli F,Coinu A,Lonati V,et al (2015) A systematic review and meta-analysis of adjuvant chemotherapy after neoadjuvant treatment and surgery for rectal cancer.Int J Colorectal Dis. 30:447–457.
Ejaz A, Casadaban L, Maker AV (2017) Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis. J Surg Res. 215:12–20.
Babcock BD, Aljehani MA, Jabo B, et al (2018) High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal. Ann Surg Oncol. 25:1980–1985.
Nozawa H, Kawai K, Hata K, et al (2018) High-risk Stage II Colorectal Cancers Carry an Equivalent Risk of Peritoneal Recurrence to Stage III. In Vivo. 32:1235–1240.
Knijn N, Mogk SC, Teerenstra S, et al (2016) Perineural Invasion Is a Strong Prognostic Factor in Colorectal Cancer A Systematic Review.Am J Surg Pathol. 40:103–112.
Horvat N, Petkovska I, Gollub MJ (2018) MR imaging of rectal cancer. Radiol Clin North Am 2018; 56:751–774.
Liebig C, Ayala G, Wilks JA, et al (2009) Perineural invasion in cancer: a review of the literature.Cancer. 115:3379–3391.
Cienfuegos JA, Rotellar F, Baixauli J, et al (2014) Impact of perineural and lymphovascular invasion on oncological outcomes in rectal cancer treated with neoadjuvant chemoradiotherapy and surgery. Ann Surg Oncol. 22:916–923.
Huang CM, Huang CW, Huang MY, et al (2014) Coexistence of perineural invasion and lymph node metastases is a poor prognostic factor in patients with locally advanced rectal cancer after preoperative chemoradiotherapy followed by radical resection and adjuvant chemotherapy. Med Princ Pract. 23:465–470.
Dhadda AS, Bessell EM, Scholefield J, et al (2014) Mandard tumour regression grade, perineural invasion, circumferential resection margin and post-chemoradiation nodal status strongly predict outcome in locally advanced rectal cancer treated with preoperative chemoradiotherapy. Clin Oncol (R Coll Radiol). 26:197–202.
Quanquan Sun, Tongxin Liu, Peng Liu et al (2019) Perineural and lymphovascular invasion predicts for poor prognosis in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery. J Cancer. 10:2243–2249.
Ceyhan GO, Liebl F, Maak M, et al (2010) The severity of neural invasion is a crucial prognostic factor in rectal cancer independent of neoadjuvant radiochemotherapy. Ann Surg. 252:797–804.
Yang Y, Huang X, Sun J, et al (2015) Prognostic Value of Perineural Invasion in Colorectal Cancer: A Meta-Analysis. J Gastrointest Surg. 19:1113–1122.
Cienfuegos JA, Martínez P, Baixauli J, et al (2017) Perineural Invasion is a Major Prognostic and Predictive Factor of Response to Adjuvant Chemotherapy in Stage I-II Colon Cancer.Ann Surg Oncol. 24:1077–1084.
Lino-Silva LS, Salcedo-Hernández RA, España-Ferrufino, et al (2017) A Extramural perineural invasion in pT3 and pT4 rectal adenocarcinoma as prognostic factor after preoperative chemoradiotherapy. Hum Pathol. 65:107–112.
Huang Y, He L, Dong D, et al (2018) Individualized prediction of perineural invasion in colorectal cancer: development and validation of a radiomics prediction model. Chin J Cancer Res. 30:40–50.
Huang X, Liu J, Wu G, et al (2019) Development and Validation of a Nomogram for Preoperative Prediction of Perineural Invasion in Colorectal Cancer. Med Sci Monit.25:1709–1717.
Chen J, Chen Y, Zheng D, et al (2020) Pretreatment MR-Based Radiomics Signature as Potential Imaging Biomarker for Assessing the Expression of Topoisomerase II alpha (TOPO-IIα) in Rectal Cancer. J Magn Reson Imaging.51:1881–1889.
Zhang H, Li W, Hu F, et al (2019) MR texture analysis: Potential imaging biomarker for predicting the chemotherapeutic response of patients with colorectal liver metastases. Abdom Radiol 44: 65–71.
Cui Y, Yang X, Shi Z, et al (2019) Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Eur Radiol 29:1211–1220.
Edge SB, Byrd DR, Compton CC, et al (2019) AJCC cancer staging manual. 7th ed. New York: Springer.
Zhang M, Zhu ZL, Gao XL, et al (2018) Functions of chemokines in the perineural invasion of tumors (Review).Int J Oncol. doi: 10.3892/ijo.2018.4311.
Bakst RL, Wong RJ (2016) Mechanisms of Perineural Invasion. J Neurol Surg B Skull Base.77:96–106.
Tibshirani R (2011) Regression shrinkage and selection via the lasso: a retrospective. Journal of the Royal Statistical Society Series. B-Statistical Methodology.73:273–282.
Zhang JX, Song W, Chen ZH, et al (2013) Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. Lancet Oncol. 14:1295–1306.
Chawla NV, Bowyer KW, Hall LO, Kegelmeyer WP (2002) SMOTE: synthetic minority over-sampling technique. J Artif Intell Re.16:321–357.
Huang YQ, Liang CH, He L, et al (2016) Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol 34:2157–2164.
Krasna MJ, Flancbaum L, Cody RP, et al (1988) Vascular and neural invasion in colorectal carcinoma. Incidence and prognostic significance. Cancer 61:1018–1023.
Díaz Beveridge R, Akhoundova D, Bruixola G, et al (2017) Controversies in the multimodality management of locally advanced rectal cancer. Med Oncol 34:102.
Nikberg M, Chabok A, Letocha H, et al (2016) Lymphovascular and perineural invasion in stage II rectal cancer: a report from the Swedish colorectal cancer registry. Acta Oncol 55:1418–1424.
Kinugasa T, Mizobe T, Shiraiwa S, et al (2017) Perineural Invasion Is a Prognostic Factor and Treatment Indicator in Patients with Rectal Cancer Undergoing Curative Surgery: 2000-2011 Data from a Single-center Study. Anticancer Res 37:3961–3968.
Liebig C, Ayala G, Wilks J, et al (2009)Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol 27:5131–5137.
Ueno H, Hase K, Mochizuki H (2001)Criteria for extramural perineural invasion as a prognostic factor in rectal cancer. Br J Surg 88:994–1000.
Poeschl EM, Pollheimer MJ, Kornprat P, et al (2010) Perineural invasion: correlation with aggressive phenotype and independent prognostic variable in both colon and rectum cancer. J Clin Oncol 28:e358–e360 [author reply e361–e362].
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Chen, J., Chen, Y., Zheng, D. et al. Pretreatment MR-based radiomics nomogram as potential imaging biomarker for individualized assessment of perineural invasion status in rectal cancer. Abdom Radiol 46, 847–857 (2021). https://doi.org/10.1007/s00261-020-02710-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-020-02710-4